Frequency Electronics (FEIM) Competitors

Cytek Biosciences (NASDAQ:CTKB) and Frequency Electronics (NASDAQ:FEIM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, community ranking, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Do analysts recommend CTKB or FEIM?

Cytek Biosciences presently has a consensus price target of $6.42, indicating a potential upside of 72.96%. Given Cytek Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Cytek Biosciences is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytek Biosciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Frequency Electronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is CTKB or FEIM more profitable?

Frequency Electronics has a net margin of 13.02% compared to Cytek Biosciences' net margin of -5.05%. Frequency Electronics' return on equity of 21.49% beat Cytek Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytek Biosciences	-5.05%	-2.58%	-2.05%
Frequency Electronics	13.02%	21.49%	9.71%

Which has more volatility and risk, CTKB or FEIM?

Cytek Biosciences has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Frequency Electronics has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

Which has preferable earnings and valuation, CTKB or FEIM?

Frequency Electronics has lower revenue, but higher earnings than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytek Biosciences	$200.45M	2.37	-$12.15M	-$0.05	-74.20
Frequency Electronics	$65.40M	2.75	$5.59M	$2.41	7.72

Does the media refer more to CTKB or FEIM?

In the previous week, Cytek Biosciences had 3 more articles in the media than Frequency Electronics. MarketBeat recorded 6 mentions for Cytek Biosciences and 3 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.57 beat Cytek Biosciences' score of 0.85 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytek Biosciences	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Frequency Electronics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Does the MarketBeat Community believe in CTKB or FEIM?

Frequency Electronics received 66 more outperform votes than Cytek Biosciences when rated by MarketBeat users. Likewise, 60.69% of users gave Frequency Electronics an outperform vote while only 45.83% of users gave Cytek Biosciences an outperform vote.

Company	Underperform	Outperform
Cytek Biosciences	Outperform Votes 22 45.83%	Underperform Votes 26 54.17%
Frequency Electronics	Outperform Votes 88 60.69%	Underperform Votes 57 39.31%

Do institutionals & insiders have more ownership in CTKB or FEIM?

69.5% of Cytek Biosciences shares are owned by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are owned by institutional investors. 9.6% of Cytek Biosciences shares are owned by company insiders. Comparatively, 26.1% of Frequency Electronics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Frequency Electronics beats Cytek Biosciences on 11 of the 18 factors compared between the two stocks.